The progression of Alzheimer’s disease has long been understood as a relentless march of cellular destruction, fueled by the accumulation…
Read More
High-Dose Fish Oil Supplements Fail to Slow Cognitive Decline in Older Adults at Risk for Alzheimer’s Disease Despite Successful Brain Penetration
The multi-billion-dollar global industry built around omega-3 fatty acid supplements has faced a significant scientific setback following the release of…
Read More
Baylor College of Medicine Researchers Identify Tubulin as a Key Protective Factor Against Alzheimer’s and Parkinson’s Disease Pathogenesis
In a landmark study that may redefine the therapeutic landscape for neurodegenerative disorders, scientists at Baylor College of Medicine have…
Read More
Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study
A comprehensive investigation led by researchers at UCLA Health has established a definitive and alarming link between long-term residential exposure…
Read More
Ionis Pharmaceuticals and Recordati Forge Global Partnership for Zilganersen in Alexander Disease
Ionis Pharmaceuticals has forged a significant global licensing agreement with Recordati, a prominent international pharmaceutical company, granting Recordati exclusive rights…
Read More
Cancer-Driving Mutations in Brain Immune Cells Linked to Alzheimer’s Disease Progression and New Diagnostic Pathways
In a landmark study that bridges the fields of oncology and neurology, researchers at Boston Children’s Hospital have identified a…
Read More
Competition Between Amyloid Beta and Tau for Microtubule Binding Sites Offers New Insight into the Early Pathogenesis of Alzheimer’s Disease
Researchers at the University of California, Riverside (UCR) have unveiled a provocative new theory regarding the molecular origins of Alzheimer’s…
Read More
Breakthrough Molecule OLE Offers New Hope for Restoring Brain Immune Function in Alzheimer Disease Patients
In a significant advancement for neurodegenerative research, a collaborative team of scientists from Spain and Switzerland has identified an experimental…
Read More
Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential
Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…
Read More
How CTF is trying to rescue pharma’s shelved rare disease drugs
Across the global pharmaceutical landscape, an estimated 5,000 potential treatments for rare diseases are currently languishing on corporate shelves, representing…
Read More
